Related Experiment Video
Updated: Feb 15, 2026

Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 23, 2013
A genetic approach to evaluation of short stature of undetermined cause
Philip G Murray1, Peter E Clayton1, Steven D Chernausek2
1Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Division of Developmental Biology and Medicine, School of Medical Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK.
Insights
Genetic testing can provide molecular diagnoses for 25-40% of children with idiopathic short stature. This diagnosis is crucial for guiding treatment decisions, such as growth hormone or insulin-like growth factor 1 therapy.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Molecular Diagnostics
Background:
- Short stature is a frequent reason for pediatric endocrinology consultations.
- Idiopathic short stature (ISS) is diagnosed after excluding other medical conditions.
- Genetic factors significantly influence human height.
Purpose of the Study:
- To review the utility of advanced genetic studies in diagnosing ISS.
- To estimate the diagnostic yield of molecular genetic testing in ISS.
- To highlight the importance of molecular diagnoses for treatment decisions.
Main Methods:
- Review of genetic studies including copy number variant analysis.
- Application of targeted gene panels.
- Utilization of whole-exome sequencing in pediatric ISS cases.
Main Results:
- Genetic technologies can identify a molecular diagnosis in an estimated 25-40% of children with ISS.
- These advanced genetic approaches are increasingly applicable to ISS diagnosis.
Conclusions:
- Molecular genetic testing offers significant diagnostic potential for children with idiopathic short stature.
- A confirmed molecular diagnosis can inform personalized treatment strategies, including growth hormone and IGF-1 therapies.
Abstract:
Short stature is a common presentation to paediatric endocrinologists. After exclusion of major endocrine or systemic disease, most children with short stature are diagnosed based on a description of their growth pattern and the height of their parents (eg, familial short stature). Height is a polygenic trait and genome-wide association studies have identified many of the associated genetic loci. Here we review the application of genetic studies, including copy number variant analysis, targeted gene panels, and whole-exome sequencing in children with idiopathic short stature. We estimate 25-40% of children diagnosed with idiopathic short stature could receive a molecular diagnosis using these technologies. A molecular diagnosis for short stature is important for affected individuals and their families and might inform treatment decisions surrounding use of growth hormone or insulin-like growth factor 1 therapy.
Related Concept Videos
Genetics of Speciation
What is Population Genetics?
What is Genetic Engineering?
Short-distance Transport of Resources
Power System Three-Phase Short Circuits
Animal Mitochondrial Genetics

